We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

NZ Bans Avandia Over Cardiovascular Concerns

Law360 (February 18, 2011, 1:39 PM EST) -- New Zealand’s health regulator is pulling diabetes drug Avandia from the shelves, saying a safety review found the medication increased patients’ risk of developing cardiovascular problems.

The New Zealand Ministry of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.